[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349247-105":59,"doc-detail-349247-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","a-multi-omics-framework-reveals-tumor-heterogeneity-and-predicts-therapeutic-targets-in-renal-cell-carcinoma","A Multi-Omics Framework Reveals Tumor Heterogeneity and Predicts Therapeutic Targets in Renal Cell Carcinoma","","Tumor cell heterogeneity and multicellular interactions drive drug resistance, recurrence, and prognosis. A computational multi-omics framework (CPcellsubpopulation) was built by integrating scRNA-seq, bulk RNA-seq, and clinical data to define cancer progression-associated cell subpopulations. Integrated scRNA-seq and spatial transcriptomics analyses predicted cell interactions, prioritized transcription factors, and nominated candidate anticancer drugs. Across nine cancers, conserved patterns linked subpopulations to prognosis, with RCC-specific findings including metabolichigh UBE2C+ cancer cells and PLK1+ immune subsets mapped to advanced disease and key pathway signals.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/a-multi-omics-framework-reveals-tumor-heterogeneity-and-predicts-therapeutic-targets-in-renal-cell-carcinoma/349247/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/a-multi-omics-framework-reveals-tumor-heterogeneity-and-predicts-therapeutic-targets-in-renal-cell-carcinoma/349247.png","ImageObject",300,407,{"name":92,"@type":93},"Pentious","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is CPcellsubpopulation and what data does it integrate?","Question",{"text":112,"@type":113},"CPcellsubpopulation is a computational framework integrating scRNA-seq, bulk RNA-seq, and clinical data to identify cancer progression-associated cell subpopulations.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were drug candidates and transcription factors predicted?",{"text":117,"@type":113},"The study combined integrated analyses of scRNA-seq and spatial transcriptomics to predict potential interactions, identify critical transcription factors, and nominate candidate anticancer drugs.",{"name":119,"@type":110,"acceptedAnswer":120},"What RCC-specific cell populations were linked to poor outcomes?",{"text":121,"@type":113},"In renal cell carcinoma, metabolichigh UBE2C+ cancer cells were associated with poor prognosis, along with PLK1+ NK cells, plasma cells, and CDC20+ macrophages linked to advanced stages and unfavorable outcomes.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},349247,1790199638,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374404730887,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Article  \nA Multi-Omics Framework Reveals Tumor Heterogeneity and Predicts Therapeutic Targets in Renal Cell Carcinoma  \nXiangzhe Yin, Zihe Zhou, Yunzhu Xue, Yangxinyue Zheng, Wentong Yu, Zhichao Geng, Yanwu Sun , Lu Wang, Zushun Chen, Siyao Wang, Li Wang * and Hongying Zhao *  \nAcademic Editor: Hyunsoo Kim  \nReceived: 10 April 2026  \nRevised: 5 May 2026  \nAccepted: 13 May 2026  \nPublished: 15 May 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \nCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, China  \n* [Correspondence: wangli@hrbmu.edu.cn](Correspondence: wangli@hrbmu.edu.cn) (L.W.); [zhaohongying@hrbmu.edu.cn](zhaohongying@hrbmu.edu.cn) (H.Z.)  \nAbstract  \nTumor cell heterogeneity and multicellular interactions critically influence drug resistance, recurrence, and prognosis. Here, CPcellsubpopulation, a computational framework integrating scRNA-seq, bulk RNA-seq, and clinical data was developed to identify cancer progression-associated cell subpopulations. Then, the integrated analyses of scRNA-seq and spatial transcriptomics were performed to predict potential interactions, identify critical transcription factors, and predict candidate anticancer drugs. Across nine cancers, we detected cancer progression-associated cell subpopulations significantly linked to prognosis, with consistent patterns across cancer types. In renal cell carcinoma (RCC), we identified conserved metabolichigh UBE2C+ cancer cells linked to poor outcomes, metabolic reprogramming and low differentiation, and PLK1+ NK cells, plasma cells, and CDC20+ macrophages associated with advanced stages and unfavorable prognosis. Spatial mapping revealed spatial association of RCC progression-associated cancer and immune cell subpopulations, suggesting the potential role of the VEGF, GDF, PTN and IL16 pathways in theremodeling of the tumor microenvironment. Gene regulatory network analysis highlighted RAD21 as a key regulator linking metabolism and therapy resistance. This study provides a systematic pipeline to delineate cancer progression-associated cell subpopulations, uncovers metabolichigh UBE2C+ cancer cells as progression-associated tumor cell population, and nominates critical regulators and compounds as therapeutic targets.  \nKeywords: multi-omics analysis; spatial transcriptomics; metabolic reprogramming; renal cell carcinoma; gene regulatory networks  \n1. Introduction  \nKidney cancer is the seventh most common cancer in the world, and its incidence is on the rise. Renal cell carcinoma (RCC) is the most common form and is a heterogeneous disease [1] . RCC progression involves abnormalities in multiple malignant cell populationsand tumor microenvironment (TME), as well as alterations in their molecular communications [2] . The tumor microenvironment of RCC is accompanied by a high level of terminally exhausted CD8+ T cells and suppressive M2-like macrophages, which leads to severe immunosuppression and immune resistance [3] . The occurrence and progression of RCC originating from multi-step genetic alterations may lead to abnormal gene expression. PABPC1L promotes immune escape and immunosuppression inRCC by upregulating IDO1, inducing T-cell dysfunction [4] . Tumor cells promote their growth, progression, and metastasis by releasing soluble factors and recruiting cells, and gradually induce phenotypic  \nchanges in TME [5] . However, the phenotypic heterogeneity and location relationships of tumor cells and immune cells in RCC remain elusive.  \nWith the advent of single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics (ST), these technologies have been regarded as unprecedented tools to dissect a comprehensive gene expression atlas and spatial arrangement information [6] . At the single-cell level, fibroblast-derived FGF7 triggers AKT activati","cbCaiaSpx6TiuoEb","https://ap.wps.com/l/cbCaiaSpx6TiuoEb","pdf",5709619,23,"English","# Abstract\n# Introduction\n# Results\n## Identification of Cancer Progression-Associated Cell Subpopulations Across Cancer Types","[{\"question\":\"What is CPcellsubpopulation and what data does it integrate?\",\"answer\":\"CPcellsubpopulation is a computational framework integrating scRNA-seq, bulk RNA-seq, and clinical data to identify cancer progression-associated cell subpopulations.\"},{\"question\":\"How were drug candidates and transcription factors predicted?\",\"answer\":\"The study combined integrated analyses of scRNA-seq and spatial transcriptomics to predict potential interactions, identify critical transcription factors, and nominate candidate anticancer drugs.\"},{\"question\":\"What RCC-specific cell populations were linked to poor outcomes?\",\"answer\":\"In renal cell carcinoma, metabolichigh UBE2C+ cancer cells were associated with poor prognosis, along with PLK1+ NK cells, plasma cells, and CDC20+ macrophages linked to advanced stages and unfavorable outcomes.\"}]","A Multi-Omics Framework Reveals Tumor Heterogeneity and Predicts Therapeutic Targets in Renal Cell Carcinoma | PDF",1790082433,58,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6b4efbb71b88b930fbc5c7d0768c57c1.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9882cff9baf30e8e45d5692b8fd6f5b4.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/54176c97847a28d6e558774793b41754.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bc9bf5d7485c9aff3d9e2b31f2c00bd8.webp",980,1385]